Huppke, Peter <br/><br/>
JC virus antibody status in a pediatric multiple sclerosis cohort: prevalence, conversion rate and influence on disease severity.  [electronic resource] 

 -  Multiple sclerosis (Houndmills, Basingstoke, England)  Apr 2015 
 - 382-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1477-0970 
<br/><br/><label>Standard No.: </label>10.1177/1352458514543340  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antibodies, Viral--blood<br/>Child<br/>Cohort Studies<br/>Female<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>JC Virus<br/>Male<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Natalizumab--therapeutic use<br/>Polyomavirus Infections--epidemiology<br/>Prevalence<br/>Seroconversion<br/>Seroepidemiologic Studies